Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jun 2026 for Centessa Pharmaceuticals plc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
John J. Crowley: trading record in brief
John J. Crowley (finance chief) discloses dealings in 2 companies, chiefly Centessa Pharmaceuticals plc and Fusion Pharmaceuticals Inc. Between 31 August 2021 and 24 June 2026, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 24 June 2026 came the latest disclosure, a transaction in Centessa Pharmaceuticals plc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John J. Crowley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
45,000 sharesOrdinary SharesSEC:0001470831-26-000620:0
45,000 shares0Ordinary SharesSEC:0001470831-26-000096:0
10,410 sharesCommon StockSEC:0000950170-24-068893:0
3,910 sharesCommon StockSEC:0001209191-22-007050:0
4 of 4 declarations
